Immunohistochemical (IHC) analysis using our in-house SeP antibody (BD1), which recognizes the N-terminal region [38], showed reduced SeP protein levels in tumor regions compared to adjacent normal regions in liver tissue sections from HCC patients (Fig. 1A). This evidence concerns the gene SELENOP and neoplasm.